Canine atopic dermatitis is a chronic, itchy inflammatory skin condition that significantly impairs quality of life and requires sustained, multimodal management.
Canine atopic dermatitis imposes a welfare burden that is easy to underestimate because itching is not visually dramatic. Yet chronic pruritus is genuinely distressing — dogs with severe CAD scratch and bite at themselves throughout the day and night, disrupting sleep, causing self-inflicted wounds, and creating a constant background of discomfort. Validated quality-of-life instruments show that poorly controlled CAD significantly impairs dog welfare across multiple domains. The good news is that modern treatment has transformed outcomes for atopic dogs: targeted biologics and small molecule therapies can reduce itch to near-zero in well-managed patients. The welfare standard should be effective itch control — not mere reduction — combined with allergen management, barrier support, and infection treatment when indicated.